Tess Burleson - Jun 7, 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/ David J. Arthur, Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Jun 7, 2022
Transactions value $
$4,986
Form type
4
Date filed
6/8/2022, 03:14 PM
Previous filing
Jan 21, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $4.99K +27.7K +636.78% $0.18 32.1K Jun 7, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.